Citations for
1HCST, KLRK1
Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.
Benitez AC, Dai Z, Mann HH, Reeves RS, Margineantu DH, Gooley TA, Groh V, Spies T.
Proc Natl Acad Sci U S A 108(10):4081-6. Epub 2011 Feb 14. 2011
2HCST
A possible mechanism of impaired NK cytotoxicity in cancer patients: down-regulation of DAP10 by TGF-beta1.
Lee JC, Lee KM, Ahn YO, Suh B, Heo DS.
Tumori 97(3):350-7. doi: 10.1700/912.10124. 2011
3HCST
DAP10 contributes to CD8(+) T cell-mediated cytotoxic effector mechanisms during Mycobacterium tuberculosis infection.
Hessmann M, Rausch A, Rückerl D, Adams PS, Simon M, Gilfillan S, Colonna M, Ehlers S, Hölscher C.
Immunobiology 216(5):639-47. Epub 2010 Sep 24. 2011
4HCST, KLRK1
Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.
Park YP, Choi SC, Kiesler P, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE.
Blood 118(11):3019-27. doi: 10.1182/blood-2011-04-346825. Epub 2011 Aug 3. 2011
5HCST, HMBOX1, KLRK1
HMBOX1 negatively regulates NK cell functions by suppressing the NKG2D/DAP10 signaling pathway.
Wu L, Zhang C, Zhang J.
Cell Mol Immunol 8(5):433-40. doi: 10.1038/cmi.2011.20. Epub 2011 Jun 27. 2011
6HCST, TREM2, TYROBP
TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
Peng Q, Malhotra S, Torchia JA, Kerr WG, Coggeshall KM, Humphrey MB.
Sci Signal 3(122):ra38. 2010
7HCST
Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.
Orr MT, Sun JC, Hesslein DG, Arase H, Phillips JH, Takai T, Lanier LL.
J Exp Med 206(4):807-17. Epub 2009 Mar 30. 2009
8HCST, KLRK1
The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
Roda-Navarro P, Reyburn HT.
J Biol Chem 284(24):16463-72. Epub 2009 Mar 26. 2009
9CLEC5A, HCST, TYROBP
Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12.
Inui M, Kikuchi Y, Aoki N, Endo S, Maeda T, Sugahara-Tobinai A, Fujimura S, Nakamura A, Kumanogoh A, Colonna M, Takai T.
Proc Natl Acad Sci U S A 106(12):4816-21. Epub 2009 Feb 27. 2009
10HCST, TYROBP
DAP10- and DAP12-associated receptors in innate immunity.
Lanier LL.
Immunol Rev 227(1):150-60. Review. 2009
11HCST, TYROBP
A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.
Chen X, Bai F, Sokol L, Zhou J, Ren A, Painter JS, Liu J, Sallman DA, Chen YA, Yoder JA, Djeu JY, Loughran TP, Epling-Burnette PK, Wei S.
Blood 113(14):3226-34. Epub 2008 Dec 15. 2009
12HCST, KLRK1
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
Horng T, Bezbradica JS, Medzhitov R.
Nat Immunol 8(12):1345-52. Epub 2007 Oct 21. 2007
13HCST
Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity.
Hyka-Nouspikel N, Phillips JH.
Immunol Rev 214:106-17. Review. 2006
14HCST
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
Andre P, Castriconi R, Espeli M, Anfossi N, Juarez T, Hue S, Conway H, Romagne F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P.
Eur J Immunol 34(4):961-71. 2004
15HCST, PLOSL1, TYROBP
DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family.
Wilson MJ, Lindquist JA, Trowsdale J.
Immunol Res 22(1):21-42. Review. 2000
16HCST, TYROBP
Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties.
Chang C, Dietrich J, Harpur AG, Lindquist JA, Haude A, Loke YW, King A, Colonna M, Trowsdale J, Wilson MJ.
J Immunol 163(9):4651-4 1999
17KLRC4, HCST
An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH.
Science 285(5428):730-2. 1999